O
AGIO icon

OppenheimerFunds’s Agios Pharmaceuticals AGIO Stock Holding History

OppenheimerFunds’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$22.3M Buy
330,652
+36,460
+12% +$2.12M 0.03% 503
2018
Q4 		$13.6M Buy
294,192
+58,217
+25% +$3.59M 0.02% 605
2018
Q3 		$18.2M Buy
235,975
+52,840
+29% +$4.25M 0.02% 608
2018
Q2 		$15.4M Buy
183,135
+20,552
+13% +$1.79M 0.02% 641
2018
Q1 		$13.3M Buy
162,583
+20,300
+14% +$1.57M 0.02% 652
2017
Q4 		$8.13M Buy
142,283
+124,035
+680% +$7.8M 0.01% 761
2017
Q3 		$1.22M Buy
+18,248
New +$1.1M ﹤0.01% 1100

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return